logo-large
  • Browse Categories

Publications by authors named "David A Revelli"

Claim this Profile
I
Inhalation delivery dramatically improves the efficacy of topotecan for the treatment of local and distant lung cancer.
Philip J Kuehl, Christin M Yingling, Devon Dubose, Michael Burke, David A Revelli

Drug Deliv· December 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming.
Philip J Kuehl, Carmen S Tellez, Marcie J Grimes, Thomas H March, Mathewos Tessema, David A Revelli

Br J Cancer· April 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model.
Philip J Kuehl, Marcie J Grimes, Devon Dubose, Michael Burke, David A Revelli

Drug Deliv· November 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis.
David A Revelli, Julie A Boylan, Frank C Gherardini

Front Cell Infect Microbiol· December 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: